ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,868.55
-0.22%
Dow Jones
42,392.27
-0.36%
US Dollar vs MXN
20.55156
-0.27%
Brent Oil
76.005
0.20%
Bitcoin
96,646.00
-0.26%
Pepperstone
Advertisement
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Tonix Pharmaceuticals Holding Corporation (TNXP)

  7. Tonix Pharmaceuticals Holding Corporation (TNXP) Noticias

TNXP

Tonix Pharmaceuticals (TNXP)

Tonix Pharmaceuticals Holding Corporation
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:TNXP
FechaHoraFuenteTítuloSímboloCompañía
23/12/202407:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
23/12/202407:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces PDUFA Goal Date of August 15, 2025, for FDA Decision on U.S. Marketing Approval for TNX-102 SL for FibromyalgiaNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
20/12/202415:16Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
17/12/202408:25AllPennyStocks.comThis Micro Cap Is Getting Bid Up Prior To Opening BellNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
17/12/202407:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (NDA) for TNX-102 SL for FibromyalgiaNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
06/12/202415:13Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
03/12/202406:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Expansion of Leadership Team with Two Strategic HiresNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
26/11/202406:00GlobeNewswire Inc.Tonix Pharmaceuticals to Participate in the NobleCon20 Investor ConferenceNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
18/11/202415:05GlobeNewswire Inc.Tonix Pharmaceuticals to Present at the Winter 2024 Investor Summit VirtualNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
18/11/202406:00GlobeNewswire Inc.Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American College of Rheumatology (ACR) Convergence 2024 Annual MeetingNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
14/11/202415:42Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
13/11/202415:05GlobeNewswire Inc.Tonix Pharmaceuticals Announces Poster Presentation at the American College of Rheumatology (ACR) Convergence 2024 Annual MeetingNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
13/11/202408:05GlobeNewswire Inc.Tonix Pharmaceuticals Announces Peer-Reviewed Publication in mSphere Journal Highlighting the Tolerability of Company’s Single-Dose Mpox and Smallpox Vaccine Candidate TNX-801, in Immune-Compromised AnimalsNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
12/11/202416:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
12/11/202407:00GlobeNewswire Inc.Tonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational HighlightsNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
04/11/202406:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Research Agreement with Kenya Medical Research Institute (KEMRI) to Design, Plan and Seek Regulatory Approval for a Phase I Clinical Study of TNX-801 for Mpox in KenyaNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
01/11/202406:00GlobeNewswire Inc.Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress-Europe 2024NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
29/10/202407:00GlobeNewswire Inc.Tonix Pharmaceuticals to Present at BIO-Europe® 2024NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
25/10/202407:00GlobeNewswire Inc.Tonix Pharmaceuticals to Present at the 2024 ThinkEquity ConferenceNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
24/10/202407:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Oral Presentation at the World Vaccine Congress Europe 2024NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
17/10/202407:00GlobeNewswire Inc.Tonix Pharmaceuticals Receives First Contract Payment from U.S. Department of Defense for Accelerated Development of Broad-Spectrum Antivirals with the Defense Threat Reduction Agency (DTRA)NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
16/10/202407:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Submission of the TNX-102 SL New Drug Application (NDA) for Fibromyalgia to the U.S. Food and Drug Administration (FDA)NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
08/10/202407:30GlobeNewswire Inc.Tonix Pharmaceuticals Announces AI Collaboration with X-Chem to Develop Broad-Spectrum AntiviralsNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
30/09/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
30/09/202406:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Participation in Endpoints Panel at the Long COVID Workshop and RECOVER TLC Workshop Convened by the Foundation for the National Institutes of Health (FNIH) and the National Institute of Allergy and Infectious Diseases (NIAINASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
27/09/202406:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Issuance of U.S. Patent Covering the Subcutaneous Delivery of FDA-Approved Zembrace® SymTouch® to Treat MigrainesNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
23/09/202416:09Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
23/09/202406:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Data Presentations on TNX-102 SL for Fibromyalgia at the 11th Global Conference on Pharmaceutics and Novel Drug Delivery Systems (PDDS 2024)NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
20/09/202416:03Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
19/09/202406:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Issuance of U.S. Patent by the United States Patent and Trademark Office Covering the Intranasal Delivery of FDA-Approved Tosymra® to Treat MigrainesNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
 Showing the most relevant articles for your search:NASDAQ:TNXP

Su Consulta Reciente

TG
230956
Schweizerische Eidgenoss...
TG
A1905C
Wurth Finance
LSE
BP55
Kin Bahrain.36s
UNSW3
BONDETH
BarnBridge Governance Token
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados